After seven months of searching, Landos hires a CEO; Marty Duvall re-emerges from ill-fated Oncopeptides tenure
Landos Biopharma has landed a new CEO after seven months of being led by an interim chief executive.
Gregory Oakes took the helm of the autoimmune biotech this month, bringing with him nearly 30 years of industry chops, most recently as president of Vifor Pharma’s North America division and, before that, VP at Celgene. Oakes also spent a better part of the 2010s at Novartis, making his way up to head of biopharmaceuticals for generics division Sandoz.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
